For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
Case Study: Ph. Eur. Monograph 2217: Lamivudine Related Substances
This Case Study for Lamivudine and its related substances is based on the Ph. Eur. monograph where an end-capped octadecylsilyl silica gel stationary phase is used under isocratic conditions. We demonstrate the potential method improvements that can be achieved within the defined allowable adjustments of chromatographic conditions per the Ph. Eur. Monograph 2217 for Lamivudine using Luna™ Omega C18.

Case Study: Ph. Eur. Monograph 2217: Lamivudine Related Substances

This Case Study for Lamivudine and its related substances is based on the Ph. Eur. monograph where an end-capped octadecylsilyl silica gel stationary phase is used under isocratic conditions. We demonstrate the potential method improvements that can be achieved within the defined allowable adjustments of chromatographic conditions per the Ph. Eur. Monograph 2217 for Lamivudine using Luna™ Omega C18.
save_alt DOWNLOAD

Can't view? Disable your browser's pop-up blocker.

Document Type:
Technical Notes
Target Industries:
Brands:
Separation Modes:
Reversed Phase

Case Study: Ph. Eur. Monograph 2217: Lamivudine Related Substances

This Case Study for Lamivudine and its related substances is based on the Ph. Eur. monograph where an end-capped octadecylsilyl silica gel stationary phase is used under isocratic conditions. We demonstrate the potential method improvements that can be achieved within the defined allowable adjustments of chromatographic conditions per the Ph. Eur. Monograph 2217 for Lamivudine using Luna™ Omega C18.

Can't view? Disable your browser's pop-up blocker.